Patents
Sitemap › G01 - Measuring; Testing › G01N - Investigating or analysing materials by determining their chemical or physical properties › G01N 33 - Investigating or analysing materials by specific methods not covered by groups
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
05/2010
05/27/2010WO2010058974A2 Method for collectively determining sensitivity to anti-cancer therapeutic drug
05/27/2010WO2010058860A1 Measurement method and measurement reagent for c-reactive protein in sample
05/27/2010WO2010058840A1 Means for releasing drug from liposome and method for evaluating releasing characteristics
05/27/2010WO2010058815A1 Device for measuring blood component
05/27/2010WO2010058605A1 Method for evaluating state of cells
05/27/2010WO2010058590A1 Protein substance hydrolysis method, hydrolysis device, and hydrolytic product analysis device
05/27/2010WO2010058572A1 Methods for diagnosing or treating prostate cancer
05/27/2010WO2010058473A1 Optical measurement device
05/27/2010WO2010058472A1 Optical measurement device
05/27/2010WO2010058471A1 Test tool, and optical measurement device
05/27/2010WO2010058412A1 A new rapid thrombochek test kit based on whole blood screening test to detect platelet hyperaggregation at a temparature of 37°c in the clinical laboratory
05/27/2010WO2010058378A1 Methods, devices and kits for detecting or monitoring acute kidney injury
05/27/2010WO2010058303A1 Biosensor system for actuating magnetic particles
05/27/2010WO2010058253A1 Method for experimentally optic transmitting information through an optic nerve
05/27/2010WO2010058162A2 Semiconductor nanoparticle-based light emitting devices and associated materials and methods
05/27/2010WO2010058097A1 Truncated cd20 protein, deltacd20
05/27/2010WO2010058059A1 A method for detecting specific nucleotide sequences
05/27/2010WO2010057985A2 Salmonella marker vaccine
05/27/2010WO2010057983A1 Salmonella marker vaccine
05/27/2010WO2010057784A1 Fabric whiteness measurement system
05/27/2010WO2010057649A1 Method for identifying laser sintering powders with markers consisting of salts of rare earth metals
05/27/2010WO2010057647A2 Methods and compositions for the diagnosis and treatment of diabetes
05/27/2010WO2010057351A1 Method for detecting biological markers by an atomic force microscope
05/27/2010WO2010057318A1 Devices and methods for providing concentrated biomolecule condensates to biosensing devices
05/27/2010WO2010057264A1 Analyte detection assay
05/27/2010WO2010057259A1 Protein stability assay using a fluorescent reporter of protein folding
05/27/2010WO2010042228A3 Methods for predicting disease outcome in patients with colon cancer
05/27/2010WO2010040062A3 Nanoparticle labeling reagents and methods of use
05/27/2010WO2010040051A3 Membrane resident peptide in anti-cancer peptides causes tumor cell necrosis rather than apoptosis of cancer cells
05/27/2010WO2010039195A3 Screening for inhibitors of hcv amphipathic helix (ah) function
05/27/2010WO2010039180A3 High sensitivity determination of the concentration of analyte molecules or particles in a fluid sample
05/27/2010WO2010037563A9 Identification of oncofetal antigens using hybridoma libraries raised against human embryonic stem cells
05/27/2010WO2010037042A3 Methods for detecting and treating cancer
05/27/2010WO2010035129A3 Method for separating the constituents of a complex mixture of proteins to submit to proteomic analysis and apparatus therefor
05/27/2010WO2010033866A3 Monoclonal antibodies for cspg4 for the diagnosis and treatment of basal breast carcinoma
05/27/2010WO2010032022A8 Use of a protein kinase inhibitor to detect immune cells, such as t cells
05/27/2010WO2010028214A3 Screening method to identify molecules having the ability to modulate the activity of a catalyst
05/27/2010WO2010026473A3 Pta072 protein
05/27/2010WO2010022289A3 Methods for removal of specific seed tissue or structure for seed analysis
05/27/2010WO2010022286A3 Apparatus for removal of specific seed tissue or structure for seed analysis
05/27/2010WO2010021777A3 Detection of trace chemicals and method therefor
05/27/2010WO2010019519A3 Method of using foxo3a polymorphisms and haplotypes to predict and promote healthy aging and longevity
05/27/2010WO2010013933A3 Analysis method for identifying substances that modulate the interaction between rna molecules and proteins
05/27/2010WO2010008905A3 Self-assembling multicellular bodies and methods of producing a three-dimensional biological structure using the same
05/27/2010WO2010005982A3 Multiplexed biomarkers of insulin resistance
05/27/2010WO2010000591A3 Fluorescent cyclic peptides, methods for the preparation thereof, and use of said peptides for measuring the enzymatic activity of a protease enzyme
05/27/2010WO2009148616A3 Systems and methods for determining properties that affect an expression property value of polynucleotides in an expression system
05/27/2010WO2009120962A3 Protein isoforms for diagnosis
05/27/2010WO2009010725A3 Method of assessing the proliferation or differentiation behaviour of a population of target cells in a biological system
05/27/2010WO2003031572A3 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
05/27/2010US20100132056 Germ Cell Marker Using Fish Vasa Gene
05/27/2010US20100132055 Animal model for the selection and validation of agents active against pulmonary emphysema and colorectal cancer
05/27/2010US20100131432 Methods and compositions of molecular profiling for disease diagnostics
05/27/2010US20100131285 Actn3 genotype screen for athletic performance
05/27/2010US20100131258 Method for identifying protein synthesis inhibitors by ribosome structure
05/27/2010US20100131206 Identifying and Generating Olfactory Cohorts Based on Olfactory Sensor Input
05/27/2010US20100130731 Crystal structure of p53 mutants and their use
05/27/2010US20100130720 Artificial binding proteins based on a modified alpha helical region of ubiquitin
05/27/2010US20100130590 Deletion bearing bard1 isoforms and use thereof
05/27/2010US20100130585 Methods and compositions for investigation and treatment of cancer using a g-protein coupled eicosanoid receptor
05/27/2010US20100130505 Compositions and methods for inhibiting g protein signaling
05/27/2010US20100130431 Discordant helix stabilization for prevention of amyloid formation
05/27/2010US20100130419 Artery- and Vein-Specific Proteins and Uses Therefor
05/27/2010US20100130417 Transforming growth factor alpha hii
05/27/2010US20100130416 Modulation of angiogenesis by a-beta peptide fragments
05/27/2010US20100130405 Biglycan and related therapeutics and methods of use
05/27/2010US20100130404 Biomarkers for cardiodiabetes
05/27/2010US20100130402 Biomarkers for insulin resistance and beta-cell dysfunction
05/27/2010US20100130377 Predicting cancer outcome
05/27/2010US20100130375 Apolipoprotein aii assay method for the in vitro diagnosis of colorectal cancer
05/27/2010US20100130371 System, method, device, and computer program product for extraction, gathering, manipulation, and analysis of peak data from an automated sequencer
05/27/2010US20100130370 Flow cell array and the utilization thereof for multianalyte determination
05/27/2010US20100130367 Methods of Quantitatively Assessing Inflammation with Biosensing Nanoparticles
05/27/2010US20100129937 Method for measuring hyaluronic acid using hyaluronic acid binding protein
05/27/2010US20100129936 Immunoassay employing two-step internal calibration reaction
05/27/2010US20100129935 Pregnancy testing method
05/27/2010US20100129934 Glycated Insulin as a Biomarker for Diagnosis and Monitoring of Diabetes
05/27/2010US20100129933 Method for detecting the binding between mdm2 and the proteasome
05/27/2010US20100129932 Determination of Isoerythropoietins
05/27/2010US20100129931 Anti-Methylation-Controlled J Protein Antibodies and Uses Thereof
05/27/2010US20100129930 Tyrosine Phosphorylation Sites
05/27/2010US20100129929 Tyrosine Phosphorylation Sites
05/27/2010US20100129928 Tyrosine Phosphorylation Sites
05/27/2010US20100129927 Peptides for Use in Diagnosing the Presence of Ruptured Atherosclerotic Lesions in a Individual
05/27/2010US20100129924 Quality assurance method for olefin polymerization catalysts
05/27/2010US20100129923 Tandem mass spectrometry for detecting and/or screening for conditions associated with altered sterols
05/27/2010US20100129922 Devices and methods for the collection and detection of substances
05/27/2010US20100129921 Monitoring of ionic liquid catalyst deactivation
05/27/2010US20100129920 Method and system for measuring physical parameters with a piezoelectric bimorph cantilever in a gaseous or liquid environment
05/27/2010US20100129919 Methods and biomarkers for diagnosing and monitoring psychotic disorders
05/27/2010US20100129918 Compositions and methods for monitoring breast cancer treatment
05/27/2010US20100129911 Nanoparticulate Affinity Capture for Label Independent Detection System
05/27/2010US20100129898 Reagent delivery system
05/27/2010US20100129864 Novel Bacteriocins, Transport and Vector System and Method of Use Thereof
05/27/2010US20100129853 Disease markers
05/27/2010US20100129851 Methods of diagnosing muscle damage
05/27/2010US20100129847 Method for the detection of amyloid-b oligomers in body fluids
05/27/2010US20100129846 Isoform specificities of blood serum proteins and their use as differentially expressed protein biomarkers for diagnosis of breast cancer
05/27/2010US20100129842 Isobarically labeled analytes and fragment ions derived therefrom
05/27/2010US20100129841 Detection of a blood coagulation activity marker in a body fluid sample
1 ... 1025 1026 1027 1028 1029 1030 1031 1032 1033 1034 1035 1036 1037 1038 1039 1040 1041 1042 1043 1044 1045 ... 3937